Health care products maker Abbott Laboratories (NYSE: ABT) received US Food and Drug Administration approval to market its new glucose monitoring system for the nearly 26 million US diabetics who take insulin. The company said the device would be available in the US “in the coming months.”
Shares are up 2.45% at $57.64, after posting a new 52-week high of $57.66 earlier.
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
